Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: A discrete choice experiment

Haemophilia

Volumn 11, Issue 6, 2005, Pages 589-597

  Mantovani, Lorenzo G ^a,c   Monzini, M S ^a   Mannucci, P M ^a   Scalone, L ^a   Villa, M ^b   Gringeri, A ^a   Barillari, Giovanni ^d   Baudo, Francesco ^e   Billio, Atto ^f   Bizzoni, Luisa ^g   Boeri, Elio ^h   Caputo, Biagio ⁱ   Castaman, Giancarlo ^j   Contino, Laura ^k   Delios, Grazia ^l   Coppola, Antonio ^m   Dragani, Alfredo ⁿ   Feola, Giulio ^o   Bertuzzo, Daniela ^p   D'Incà, Marco ^q   Santagostino, Elena ^r   Iannaccaro, PierGiorgio ^s   Iorio, Alfonso ^t   Mancuso, Giacomo ^u   Morfini, Massimo ^v   Musso, Roberto ^w   Piseddu, Gavino ^x   Rocino, Angiola ^y   Rodorigo, Giuseppina ^z   Rossetti, Gina ^aa   Scaraggi, Francesco Antonio ^ab   Schiavoni, Mario ^ac   Schinco, PierCarla ^ad   Tagariello, Giuseppe ^ae   Tagliaferri, Annarita ^af   Targhetta, Roberto ^ag   Lombardo, Vincenzo Trapani ^ah   Zanon, Ezio ^ai   more..

^a UNIVERSITY OF MILAN   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^e OSPEDALE NIGUARDA CA GRANDA   (Italy)

^f S Maurizio Hospital   (Italy)

^g POLICLINICO UMBERTO I   (Italy)

^h G GASLINI INSTITUTE   (Italy)

ⁱ Ospedale di Macerata   (Italy)

^j SAN BORTOLO HOSPITAL   (Italy)

^k C Arrigo Children's Hospital   (Italy)

^l Ospedali Riuniti nel Chiavanese   (Italy)

^m FEDERICO II UNIVERSITY HOSPITAL   (Italy)

ⁿ SPIRITO SANTO HOSPITAL   (Italy)

^o Ospedale S Luca   (Italy)

^p OSPEDALE POLICLINICO   (Italy)

^q S MARIA NUOVA HOSPITAL   (Italy)

^r FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^s PUGLIESE CIACCIO HOSPITAL   (Italy)

^t Policlinico Universitario   (Italy)

^u Ospedale dei Bambini G Di Cristina   (Italy)

^v CAREGGI UNIVERSITY HOSPITAL   (Italy)

^w Ospedale Ferrarotto   (Italy)

^x SS Annunziata Hospital   (Italy)

^y Ospedale San Giovanni Bosco   (Italy)

^z UNIVERSITY OF BOLOGNA   (Italy)

^aa SANTA CHIARA HOSPITAL   (Italy)

^ab POLICLINICO   (Italy)

^ac Ospedale Consorziale Policlinico   (Italy)

^ad MOLINETTE HOSPITAL   (Italy)

^ae Centro Emofilia Emilio Tosatti   (Italy)

^af Azienda Ospedaliera   (Italy)

^ag Centro per lo studio e la terapia dell'emofilia   (Italy)

^ah BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^ai UNIVERSITY HOSPITAL OF PADOVA   (Italy)

more..

Author keywords

Coagulation factor concentrates; Conjoint analysis; Discrete choice experiment; Haemophilia; Inhibitor; Preferences

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR CONCENTRATE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG CHOICE; DRUG COST; DRUG DOSAGE FORM; DRUG HALF LIFE; DRUG PREFERENCE; DRUG SAFETY; HEMOPHILIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PHARMACIST; PHYSICIAN ATTITUDE; PRIMARY PREVENTION; PRIORITY JOURNAL; SUBSTITUTION THERAPY; TREATMENT PLANNING;

ADOLESCENT; ADULT; ATTITUDE OF HEALTH PERSONNEL; CHOICE BEHAVIOR; COHORT STUDIES; FACTOR IX; FACTOR VIII; HEMOPHILIA A; HEMOPHILIA B; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHARMACISTS; PHYSICIANS; SEVERITY OF ILLNESS INDEX;

EID: 27744504877     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2005.01159.x     Document Type: Article

References (37)

1. World Health Organization. Prevention and control of haemophilia: memorandum from a joint WHO/WFH meeting. Bull World Health Organ 1991; LXIX, 1: 17-26.
2. World Health Organization. Delivery of Treatment for Haemophilia. Report of a Joint WHO/WFH/ISTH Meeting. Geneva: World Health Organization, 2002.
3. Mannucci PM. Haemophilia: treatment options in the twenty-first century. J Thromb Haemost 2003; 1: 1349-55.
4. Berntorp E. Prophylactic therapy for haemophilia: early experience. Haemophilia 2003; 9(Suppl. 1): 5-9.
5. Berntorp E, Astenmark J, Bjorkman S et al. Consensus perspectives on prophylactic therapy for haemophilia: summary statement. Haemophilia 2003; 9: 1-4.
6. Furie B, Limentani SA, Rosenfield CG. A practical guide to the evaluation and treatment of haemophilia. Blood 1994; 84: 3-9.
7. Katz J. Prevalence of factor IX inhibitors among patients with haemophilia B: results of a large-scale North American survey. Haemophilia 1996; 2: 28-31.
8. Di Michele D. Inhibitors: resolving diagnostic and therapeutic dilemmas. Haemophilia 2002; 8: 280-3.
9. Kulkarni R, Aledort LM, Berntorp E et al. Therapeutic choices for patients with haemophilia and high-titer inhibitors. Am J Hematol 2001; 67: 240-6.
10. Ingerslev J. Haemophilia. Strategies for the treatment of inhibitor patients. Haematologica 2000; 85: 15-20.
11. Di Michele DM. Inhibitors in haemophilia: a primer. Haemophilia 2000; 6: 38-40.
12. Gringeri A, Mantovani LG, Scalone L, Mannucci PM. Cost of care and quality of life in hemophilia complicated by inhibitors: the COCIS Study Group. Blood 2003; 102: 2358-63.
13. Globe DR, Cunningham R, Andersen R et al. The Hemophilia Utilization Group Study (HUGS): determinants of costs of care in persons with haemophilia A. Haemophilia 2003; 9: 325-31.
14. Galanaud IJP, Pelletier-Fleury N, Logerot-Lebrun H, Lambert T. Determinants of drug costs in hospitalised patients with haemophilia. Pharmacoeconomics 2003; 21: 699-707.
15. Schramm W, Royal S, Kroner B, et al. for the European Haemophilia Economic Study Group. Clinical outcomes and resource utilization associated with haemophilia care in Europe. Haemophilia 2002; 8: 33-43.
16. Fischer K, Van Der Bom JG, Van Der Berg HM. Health-related quality of life as outcome parameter in haemophilia treatment. Haemophilia 2003; 9: 75-82.
17. Royal S, Schramm W, Berntorp E et al. Quality of life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients. Haemophilia 2002; 8: 44-50.
18. Barr RD, Saleh M, Furlong W et al. Health status and health-related quality of life associated with haemophilia. Am J Hematol 2002; 71: 152-60.
19. Naraine VS, Risebrough NA, Oh P et al. Health-related quality-of-life treatments for severe haemophilia: utility measurements using the Standard Gamble technique. Haemophilia 2002; 8: 112-20.
20. Miners AH, Sabin CA, Tolley KH, Jenkinson C, Kind P, Lee CA. Assessing health-related quality of life in individuals with haemophilia. Haemophilia 1999; 5: 378-85.
21. Cleary P. The increasing importance of patient surveys. BMJ 1999; 319: 720-1.
22. Bennett KJ, Torrance GW. Measuring Health State preferences and utilities: rating scale, time trade-off, and standard gamble techniques. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn. Philadelphia, PA: Lippincott-Raven Publishers, 1996: 253-65.
23. Luce D, Tukey J. Simultaneous conjoint measurement: a new type of fundamental measurement. J Math Psychol 1964; 1: 1-2.
24. Aristides M, Chen J, Schulz M, Williamson E, Clarke S, Grant K. Conjoint analysis of a new Chemotherapy: willingness to pay and preference for the features of raltitrexed versus standard therapy in advanced Colorectal Cancer. Pharmacoeconomics 2002; 20: 775-84.
25. Kleinman L, McIntosh E, Ryan M, Schmier J, Crawley J, Locke GR III. Willingness to pay for complete symptom relief of gastroesophageal reflux disease. Arch Intern Med 2002; 162: 1361-6.
26. Osman LM, McKenzie L, Cairns J et al. Patient weighting of importance of asthma symptoms. Thorax 2001; 56: 138-42.
27. Farrar S, Ryan M, Ross D, Ludbrook A. Using discrete choice modelling in priority setting: an application to clinical service developments. Soc Sci Med 2000; 50: 63-75.
28. Singh J, Cuttler L, Shin M, Silver JB, Neuhauser D. Medical decision-making and the patient: understanding preference patterns for growth hormone therapy using conjoint analysis. Med Care 1998; 38: AS31-45.
29. Ryan M, Hughes J. Using conjoint analysis to value surgical versus medical management of miscarriage. Health Econ 1997; 6: 261-73.
30. Mc Fadden D. Conditional Logit Analysis of Qualitative Choice Behaviour. Berkley, CA: University of California, 1973.
31. Ryan M, Farrar S. Using conjoint analysis to elicit preferences for health care. BMJ 2000; 320: 1530-3.
32. Ryan M. Using conjoint analysis to go beyond health outcomes: an application to in vitro fertilisation. Soc Sci Med 1999; 8: 535-46.
33. Pearmain D, Swanson J, Kroes E, Bradley M. Stated Preference Techniques: A Guide to Practice. Hague: Steer Davis Gleave and Hague Consulting Group, 1991.
34. Bryan S, Buxton M, Sheldon R, Grant A. Magnetic resonance imaging for the investigation of knee injuries: an investigation of preferences. Health Econ 1998; 7: 595-603.
35. Ryan M. Discrete choice experiments in health care. NICE should consider using them for patient centred evaluations of technologies. Editorial BMJ 2004; 328: 360-1
36. Laine C, Davidoff F. Patient-centered medicine. A professional evolution. JAMA 1996; 275: 152-6.
37. Smith R. Abusing patients by denying them choice. BMJ 2004; 328: 382-5.